Takimoto Chris H

CIK 00017437803 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001743780

Recent Transactions

50 trades

Award
ALX ONCOLOGY HOLDINGS INC$ALXO
Stock option (right to buy)
2026-01-20+40,400→ 40,400 total
Award
ALX ONCOLOGY HOLDINGS INC$ALXO
Common Stock (right to buy)
2025-01-21+40,400→ 40,400 total
Sale
IGM Biosciences, Inc.
Common Stock
2024-09-13$11.54/sh−1,487→ 154,331 total
Award
IGM Biosciences, Inc.
Common Stock
2024-07-19+16,250→ 155,818 total
Disposition to Issuer
IGM Biosciences, Inc.
Stock Option (right to buy)
2024-07-19−150,000→ 0 total
Award
IGM Biosciences, Inc.
Common Stock
2024-07-19+43,750→ 139,568 total
Sale
IGM Biosciences, Inc.
Common Stock
2024-06-14$7.58/sh−1,570→ 95,818 total
Award
IGM Biosciences, Inc.
Common Stock
2024-05-15$5.02/sh+3,000→ 97,388 total
Sale
IGM Biosciences, Inc.
Common Stock
2024-03-14$10.17/sh−2,535→ 94,388 total
Sale
IGM Biosciences, Inc.
Common Stock
2024-03-13$9.88/sh−2,889→ 96,923 total
Award
IGM Biosciences, Inc.
Common Stock
2024-03-12+46,250→ 99,812 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2024-03-12+92,500→ 92,500 total
Sale
IGM Biosciences, Inc.
Common Stock
2023-11-29$6.21/sh−1,180→ 53,562 total
Sale
IGM Biosciences, Inc.
Common Stock
2023-05-23$12.30/sh−1,244→ 54,757 total
Sale
IGM Biosciences, Inc.
Common Stock
2023-05-23$13.01/sh−15→ 54,742 total
Award
IGM Biosciences, Inc.
Common Stock
2023-05-15$11.71/sh+962→ 56,001 total
Award
IGM Biosciences, Inc.
Common Stock
2023-04-04+26,250→ 55,039 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2023-04-04+52,500→ 52,500 total
Sale
IGM Biosciences, Inc.
Common Stock
2023-03-14$18.73/sh−1,768→ 28,789 total
Sale
IGM Biosciences, Inc.
Common Stock
2022-12-16$18.77/sh−3,492→ 32,495 total
Sale
IGM Biosciences, Inc.
Common Stock
2022-12-16$19.36/sh−1,938→ 30,557 total
Sale
IGM Biosciences, Inc.
Common Stock
2022-11-23$21.38/sh−600→ 36,264 total
Sale
IGM Biosciences, Inc.
Common Stock
2022-11-23$21.99/sh−277→ 35,987 total
Sale
IGM Biosciences, Inc.
Common Stock
2022-05-24$17.10/sh−938→ 36,864 total
Award
IGM Biosciences, Inc.
Common Stock
2022-05-13$12.38/sh+825→ 37,802 total
Award
IGM Biosciences, Inc.
Common Stock
2022-03-15+14,477→ 36,977 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2022-03-12+75,000→ 75,000 total
Award
IGM Biosciences, Inc.
Common Stock
2022-03-12+12,500→ 22,500 total
Award
IGM Biosciences, Inc.
Common Stock
2021-11-15+10,000→ 10,000 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2021-07-30+150,000→ 150,000 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−4,570→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−70,398→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−44,710→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Common Stock
2020-04-07−3,906→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−58,114→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−113,153→ 0 total
Exercise/Conversion
Forty Seven, Inc.
Common Stock
2020-04-01$35.75/sh+2,797→ 83,101 total
Exercise/Conversion
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-01−7,020→ 70,398 total
Exercise/Conversion
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-01−11,418→ 44,710 total
Exercise/Conversion
Forty Seven, Inc.
Common Stock
2020-04-01$2.02/sh+49,627→ 53,533 total
Exercise/Conversion
Forty Seven, Inc.
Common Stock
2020-04-01$4.88/sh+8,333→ 61,866 total
Exercise/Conversion
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-01−2,797→ 113,153 total
Exercise/Conversion
Forty Seven, Inc.
Common Stock
2020-04-01$8.76/sh+11,418→ 80,304 total
Sale
Forty Seven, Inc.
Common Stock
2020-04-01$95.42/sh−79,195→ 3,906 total
Exercise/Conversion
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-01−49,627→ 58,114 total
Exercise/Conversion
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-01−8,333→ 4,570 total
Exercise/Conversion
Forty Seven, Inc.
Common Stock
2020-04-01$5.27/sh+7,020→ 68,886 total
Award
Forty Seven, Inc.
Stock Option (right to buy)
2019-12-13+115,950→ 115,950 total
Sale
Forty Seven, Inc.
Common Stock
2019-12-10$35.00/sh−10,000→ 0 total
Exercise/Conversion
Forty Seven, Inc.
Common Stock
2019-12-10$2.02/sh+10,000→ 10,000 total

Companies

Recent Filings

Address

C/O ALX ONCOLOGY HOLDINGS INC. 323 ALLERTON AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov